Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Baker Heart and Diabetes Institute
Previous studies have shown that the renal denervation procedure is safe and effective in reducing blood pressure in patients with resistant hypertension. A total of 100 participants with uncontrolled blood pressure, treated with three or more blood pressure lowering medications will be recruited into the study. Patients will be assigned to one (1) of two (2) groups with the aim of attaining blood pressure control. Participants in group 1 will be assigned to renal denervation, participants in group 2 will receive additional antihypertensive medication according to current guidelines and best practice in an attempt to reach blood pressure targets.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
systolic BP ≥140mmHg or ≥130mmHg for patients with diabetes
concurrent treatment with ≥3 anti-hypertensive drugs
You may not be if
renal artery anatomy ineligible for treatment
eGFR \<15mL/min/1.73m2 (using Modification of Diet in Renal Disease (MDRD) calculation)
female participants of childbearing potential must have negative pregnancy test prior to treatment